Keywords: ssi, licenses, fusion, proteins, sanofi, pasteur, development

SSI licenses fusion proteins to Sanofi Pasteur for development of TB vaccs

Article | 25 February 2008

Print This

Sanofi Pasteur, the vaccines division of French drug major Sanofi-Aventis, has signed a collaborative research and license agreement with the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in